ClinicalTrials.gg
Drug

Niacin clinical trials

Also written Niaspan, Nicotinic acid and Niacor.

studies test it
103
open now
11
in phase 3
22
first study started
2001

How each study uses Niacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Niacin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Jul 1957 · WAMPOCAP · NDA 011073 (FDA, Drugs@FDA)
European Union
3 Jul 2008 · Tredaptive · EMEA/H/C/000889 (EMA; in a combination; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Niacin
36
extended release niacin
8
Nicotinic Acid 50 MG Oral Tablet
2

Brand

Niaspan
22
Niacor
2

Development codes

ABT-919
1

Other names

Nicotinic acid
22
Vitamin B3
5

In one entry with another drug

Given together, or one or the other

Tredaptive
9
Vitamin B3
4
Niacin/Laropiprant
3
niacin (+) laropiprant
2
Niacin Extended Release and Lovastatin Tablets
2

Studies by the year they started

99 studies that test it; most in 2010 (9)

Studies that test Niacin, by start year
YearStudies
20012
20021
20036
20045
20055
20066
20076
20086
20096
20109
20116
20126
20142
20151
20162
20172
20184
20194
20203
20214
20224
20232
20243
20251
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
6
Phase 1
9
Phase 2
21
Phase 3
22
Phase 4
26
No phase
24

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 84

Merck Sharp & Dohme LLC (7) · Université de Sherbrooke (5) · University of Pennsylvania (4) · Kos Pharmaceuticals (4) · Sanofi (3) · University of Washington (3) · Mayo Clinic (2) · Organon and Co (2)

Often tested with

Tested in the same studies.

MK-0524 (14) · Fenofibrate (9) · Niacinamide (7) · Ezetimibe (6) · Simvastatin (6) · Atorvastatin (6) · Lovastatin (6) · Alirocumab (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5

Studies that test Niacin.

Studies

Open first, then newest update. How each study uses Niacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 103

See all 103 studies that test Niacin →

Given beside what is tested · 15 — Niacin is usual care or a partner of the new treatment
As the comparator · 9 — what is tested is compared with Niacin

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Niacin · ClinicalTrials.gg INT007883

  • MeSH (NLM) D009525NiacinConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 2679MF687ANIACINConfirmed FDA, NLM
  • RxNorm 7393One source FDA
  • NCI Thesaurus C689NiacinOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.